Clinical Trials
Clinical trials are essential in medical advances. They are designed to test the safety and efficacy of new approaches to preventing, detecting, and treating disease. Trials also look for new ways to use existing treatments, new drugs, surgical procedures and devices.
Retina Consultants of Southern Colorado is one of the leading centers for clinical trials for diseases pertaining to the retina. We firmly believe in the value of research and are proud to provide our patients with the opportunity to participate in the latest clinical trials. Our dedication has been rewarded with 13 industry awards of excellence.
Studies Closed or Completed
- Opthea OPT-302: enrolling patients with DME
- Regeneron Ruby: non-proliferative diabetic retinopathy with DME
- Samsung SB-11: patients with previously untreated wet AMD.
- Regeneron Panorama: non-proliferative diabetic retinopathy without DME
- Ophtha OPT-302-1002: patients with wet AMD and no prior treatment.
- Genentech Boulevard: non-proliferative diabetic retinopathy with DME
- Novartis HAWK EXTENSION trial: wet AMD trial
- pSivida PSV-FAI-006: non-infectious uveitis
- Genentech GR39821: patients with dry AMD and geographic atrophy
- Genentech Avenue: wet AMD
- Neurotech NTMT-03-A: PFT study
- Ophthotech Eclipse: wet AMD
- Aerpio Time-2: non-proliferative diabetic retinopathy
- Roche Ladder: wet AMD
- Ophthotech Solaris: wet AMD
- Allegro Del Mar: non-proliferative diabetic retinopathy with DME
- Genentech Stairway: wet AMD
- Allergan BEACON: dry AMD with GA
- Genentech Omaspect: dry AMD with GA
- Regeneron Capella: wet AMD
- Tyrogenex X82-OPH-201: wet AMD
- Alcon LHA510-2201: wet AMD
- Alcon HAWK: wet AMD
- Roch Spectri: dry AMD with GA
- Pan Optica PAN-01-101: wet AMD
- Allergan PALM: non-proliferative diabetic retinopathy with DME
- Regeneron R2176-3-AMD-1303: wet AMD
- pSivida PSV-FAI-001: non-infectious uveitis
- Alcon C-12-074: dry AMD with GA
- Regeneron VIEW1: wet AMD
- Alcon OSPREY: wet AMD
- Regeneron REVIEW: wet AMD
- Novartis CLFG316A2203: dry AMD with GA
- Ampio AP-05-002: non-proliferative diabetic retinopathy with DME
- Allergan Ozurdex: non-proliferative diabetic retinopathy with DME
- Regeneron VIBRANT: branch retinal vein occlusion
- Regeneron VISTA: non-proliferative diabetic retinopathy with DME
- Alcon SEE: wet AMD
- Santen SAKURA: non-infectious uveitis
- Genentech SHORE: branch retinal vein occlusion
- Genentech HARBOR: wet AMD
Reach Out Today to See if You Might Be a Candidate!
Please fill out the form, or contact Kari Winger, Research Manager at [email protected] or 719-473-9595 x152 if you want further information regarding our clinical trials.